Chronic False Positive Rapid Plasma Reagin (RPR) Tests Induced by COVID-19 Vaccination

COVID Pub Date : 2023-08-30 DOI:10.3390/covid3090090
E. Williams, Devin J. Kennedy, Michael E. Hoffer, J. M. Carreño, F. Krammer, S. Pallikkuth, S. Pahwa
{"title":"Chronic False Positive Rapid Plasma Reagin (RPR) Tests Induced by COVID-19 Vaccination","authors":"E. Williams, Devin J. Kennedy, Michael E. Hoffer, J. M. Carreño, F. Krammer, S. Pallikkuth, S. Pahwa","doi":"10.3390/covid3090090","DOIUrl":null,"url":null,"abstract":"False positive reactive plasmin reagin (RPR) reactivity following a COVID-19 vaccine has been reported, and it is therefore conceivable that individuals who receive frequent coronavirus disease 2019 (COVID-19) vaccinations may exhibit durable RPR responses. Here, we sought to investigate the extent to which repeated mRNA COVID-19 vaccines can elicit chronic false RPR reactivity in a longitudinal cohort. Participants (n = 119) in an IRB-approved (#20201026), longitudinal SARS-CoV-2 cohort study were screened for RPR reactivity via manual RPR card assays. Samples with reactive results underwent additional testing, including follow-on RPR screening at additional timepoints, confirmatory fluorescent treponemal antibody (FTA-ABS) testing and anti-nuclear antibody (ANA) testing. Medical histories were collected. We observed (n = 2) screen-positive RPR results (1.7% [2/119]) following booster vaccination, for which two individuals exhibited chronic, vaccine-induced RPR reactivity for up to 9 months following booster vaccination. Both participants were ANA-negative. It is imperative for clinicians to be mindful of the potential immunologic interference of COVID-19 vaccines with standard infectious disease assays, including RPR testing. Detailed medical histories and clinical contexts, including recent vaccination, should be reviewed prior to proceeding with distressing and invasive workups.","PeriodicalId":72714,"journal":{"name":"COVID","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"COVID","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/covid3090090","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

False positive reactive plasmin reagin (RPR) reactivity following a COVID-19 vaccine has been reported, and it is therefore conceivable that individuals who receive frequent coronavirus disease 2019 (COVID-19) vaccinations may exhibit durable RPR responses. Here, we sought to investigate the extent to which repeated mRNA COVID-19 vaccines can elicit chronic false RPR reactivity in a longitudinal cohort. Participants (n = 119) in an IRB-approved (#20201026), longitudinal SARS-CoV-2 cohort study were screened for RPR reactivity via manual RPR card assays. Samples with reactive results underwent additional testing, including follow-on RPR screening at additional timepoints, confirmatory fluorescent treponemal antibody (FTA-ABS) testing and anti-nuclear antibody (ANA) testing. Medical histories were collected. We observed (n = 2) screen-positive RPR results (1.7% [2/119]) following booster vaccination, for which two individuals exhibited chronic, vaccine-induced RPR reactivity for up to 9 months following booster vaccination. Both participants were ANA-negative. It is imperative for clinicians to be mindful of the potential immunologic interference of COVID-19 vaccines with standard infectious disease assays, including RPR testing. Detailed medical histories and clinical contexts, including recent vaccination, should be reviewed prior to proceeding with distressing and invasive workups.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
COVID-19疫苗诱导的慢性假阳性快速血浆反应素(RPR)试验
据报道,在接种COVID-19疫苗后,反应性纤溶酶反应蛋白(RPR)反应性出现假阳性,因此可以想象,频繁接种2019冠状病毒病(COVID-19)疫苗的个体可能会表现出持久的RPR反应。在此,我们试图在纵向队列中研究重复mRNA COVID-19疫苗可在多大程度上引发慢性假RPR反应性。在irb批准的纵向SARS-CoV-2队列研究(#20201026)中,参与者(n = 119)通过人工RPR卡测定筛选RPR反应性。对反应性结果的样本进行额外的检测,包括在额外的时间点进行后续的RPR筛选、确认性荧光螺旋体抗体(FTA-ABS)检测和抗核抗体(ANA)检测。收集病史。我们观察到(n = 2)强化疫苗接种后RPR筛查阳性(1.7%[2/119]),其中2人在强化疫苗接种后表现出慢性疫苗诱导的RPR反应长达9个月。两名参与者均为ana阴性。临床医生必须注意COVID-19疫苗与标准传染病检测(包括RPR检测)的潜在免疫干扰。详细的病史和临床背景,包括最近的疫苗接种,应在进行痛苦和侵入性检查之前进行审查。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Impact of COVID-19 on Dental Students’ Mental Health Status and Perception of SARS-CoV-2 Vaccine SARS-CoV-2-Related Parotitis in Children: A Narrative-Focused Review 3Cs: Unleashing Capsule Networks for Robust COVID-19 Detection Using CT Images EFCAB4B (CRACR2A/Rab46) Genetic Variants Associated with COVID-19 Fatality Comparison of the Psychological Impact of COVID-19 on Healthcare Workers between 2022 and 2023 in a Romanian COVID-19 Hub Hospital
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1